MindMaze Therapeutics Holding SA RLFTY
Set alert
0.18 USD 0.00 0.00%
At close · Oct 30
0.1779 Day range 0.1779
0.16769 52-week range 4.05
- YTD
- -93.69%
- 1 year
- -88.14%
- Open
- 0.1779
- Prev close
- 0.1779
- Mkt cap
- 30.24M
- Vol
- 2.50K
- Avg vol
- 83
- EPS
- -0.32
- P/E
- 0.00
More statistics
- Low
- 0.1779
- High
- 0.1779
6M chart
Signals (16)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| RSI: Overbought | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| RSI: Oversold | May 1, 2026 | 6 months ago |
Financial health
Altman Z-Score
-1.18 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.8×
FY 2016 5y median -2.8× FY 2025
P/S 43.7×
FY 2016 5y median 10.4× FY 2025
P/B 0.7×
FY 2016 5y median 0.7× FY 2025
P/FCF -3.9×
FY 2016 5y median -2.6× FY 2025
EV/EBITDA -2.6×
FY 2016 5y median -2.1× FY 2025
EV/Sales 31.8×
FY 2016 5y median 7.7× FY 2025
FCF Yield -25.8%
FY 2016 5y median -39.0% FY 2025
Profitability
Gross Margin 92.1%
FY 2016 5y median 77.4% FY 2025
Operating Margin -1637.9%
FY 2016 5y median -1033.0% FY 2025
Net Margin -1543.0%
FY 2016 5y median -1045.0% FY 2025
ROE -25.8%
FY 2016 5y median -34.9% FY 2025
ROIC -25.5%
FY 2016 5y median -27.2% FY 2025
ROA -19.2%
FY 2016 5y median -26.9% FY 2025
Growth (YoY)
Revenue -92.4%
FY 2016 FY 2025
Operating Income 44.3%
FY 2016 FY 2025
EPS (diluted) 42.3%
FY 2016 FY 2025
Free Cash Flow -134.1%
FY 2016 FY 2025
Financial Health
Current Ratio 1.2×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 1.1×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2016 5y median 0.8× FY 2025
Interest Coverage -39.5×
FY 2016 5y median -87.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31